What is it about?
This study is a phase II, multicenter, prospective, single-blinded, randomized controlled trial that evaluates the efficacy and safety of LDRT to the whole brain using a linear accelerator in patients with mild AD
Featured Image
Why is it important?
This study is the first randomized, single-blinded, well-controlled trial in Using ionizing radiation with mild AD of the world.
Perspectives
At now, we have had a great surprising experience with this trial. We will report our fantastic results on next year.
weon kuu chung
Kyung Hee University
Read the Original
This page is a summary of: Evaluation of Efficacy and Safety Using Low Dose Radiation Therapy with Alzheimer’s Disease: A Protocol for Multicenter Phase II Clinical Trial, Journal of Alzheimer’s Disease, September 2023, IOS Press,
DOI: 10.3233/jad-230241.
You can read the full text:
Contributors
The following have contributed to this page
